{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:38:09Z","timestamp":1791272289236,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T00:00:00Z","timestamp":1428883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008529","name":"Chiba University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008529","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Sciences","doi-asserted-by":"crossref","award":["24790529"],"award-info":[{"award-number":["24790529"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jphs.2015.04.002","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T05:15:35Z","timestamp":1428988535000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effect of enhanced expression of connexin 43 on sunitinib-induced cytotoxicity in mesothelioma cells"],"prefix":"10.1016","volume":"128","author":[{"given":"Miaki","family":"Uzu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Kashiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Yamaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2015.04.002_bib1","first-page":"70","article-title":"Mesothelioma: a review","volume":"12","author":"Mott","year":"2012","journal-title":"Ochsner J"},{"key":"10.1016\/j.jphs.2015.04.002_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jphs.2015.04.002_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11864-008-0067-z","article-title":"Mesothelioma epidemiology, carcinogenesis, and pathogenesis","volume":"9","author":"Yang","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jphs.2015.04.002_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ctrv.2011.01.001","article-title":"Advances in the biology of malignant pleural mesothelioma","volume":"37","author":"Zucali","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jphs.2015.04.002_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2014.03.006","article-title":"Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma","volume":"84","author":"Zauderer","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jphs.2015.04.002_bib6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1146\/annurev.cellbio.19.111301.144309","article-title":"Connexins and cell signaling in development and disease","volume":"20","author":"Wei","year":"2004","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.jphs.2015.04.002_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/14728222.2010.487866","article-title":"Gap junctions and connexins as therapeutic targets in cancer","volume":"14","author":"Kandouz","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jphs.2015.04.002_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1615\/CritRevOncog.v12.i3-4.30","article-title":"Downregulation of gap junctions in cancer cells","volume":"12","author":"Leithe","year":"2006","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.jphs.2015.04.002_bib9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/carcin\/17.6.1199","article-title":"Role of connexin genes in growth control","volume":"17","author":"Yamasaki","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jphs.2015.04.002_bib10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jcb.22554","article-title":"The carboxy-terminal tail of connexin43 gap junction protein is sufficient to mediate cytoskeleton changes in human glioma cells","volume":"110","author":"Crespin","year":"2010","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jphs.2015.04.002_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1254\/jphs.08327FP","article-title":"Enhanced effect of connexin 43 on cisplatin-induced cytotoxicity in mesothelioma cells","volume":"110","author":"Sato","year":"2009","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2015.04.002_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ijc.10996","article-title":"Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops","volume":"104","author":"Masood","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jphs.2015.04.002_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1159\/000176386","article-title":"Mesothelioma cell proliferation through autocrine activation of PDGF-betabeta receptor","volume":"29","author":"Honda","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jphs.2015.04.002_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<72::AID-PATH401>3.0.CO;2-0","article-title":"Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression","volume":"189","author":"Kumar-Singh","year":"1999","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jphs.2015.04.002_bib15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2006.06.3602","article-title":"Sunitinib: from rational design to clinical efficacy","volume":"25","author":"Chow","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jphs.2015.04.002_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11523-012-0220-2","article-title":"Sunitinib in pancreatic neuroendocrine tumors","volume":"7","author":"Raymond","year":"2012","journal-title":"Target Oncol"},{"key":"10.1016\/j.jphs.2015.04.002_bib17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.breast.2013.07.037","article-title":"Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer","volume":"22","author":"Curigliano","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.jphs.2015.04.002_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11060-012-0988-z","article-title":"Continuous daily sunitinib for recurrent glioblastoma","volume":"111","author":"Kreisl","year":"2013","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.jphs.2015.04.002_bib19","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1097\/JTO.0b013e3182333df5","article-title":"Brief report: a phase II study of sunitinib in malignant pleural mesothelioma. the NCIC Clinical Trials Group","volume":"6","author":"Laurie","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jphs.2015.04.002_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00280-012-2008-6","article-title":"Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma","volume":"71","author":"Camidge","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jphs.2015.04.002_bib21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3892\/ijo.2012.1524","article-title":"Connexin 43 interacts with Bax to regulate apoptosis of pancreatic cancer through a gap junction-independent pathway","volume":"41","author":"Sun","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jphs.2015.04.002_bib22","first-page":"232","article-title":"The role of key genes and pathways involved in the tumorigenesis of malignant mesothelioma","volume":"1845","author":"de Assis","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jphs.2015.04.002_bib23","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-04-1940","article-title":"Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B","volume":"11","author":"Govindan","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jphs.2015.04.002_bib24","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.2006.09.7634","article-title":"Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study","volume":"25","author":"Garland","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jphs.2015.04.002_bib25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/onc.2010.503","article-title":"Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib","volume":"30","author":"Welti","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.jphs.2015.04.002_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nrc3627","article-title":"VEGF targets the tumour cell","volume":"13","author":"Goel","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jphs.2015.04.002_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<151::AID-PATH425>3.0.CO;2-E","article-title":"Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in\u00a0vitro and in\u00a0vivo","volume":"178","author":"Langerak","year":"1996","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jphs.2015.04.002_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1097-4652(200002)182:2<290::AID-JCP18>3.0.CO;2-8","article-title":"Cleavage and inactivation of antiapoptotic Akt\/PKB by caspases during apoptosis","volume":"182","author":"Rokudai","year":"2000","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jphs.2015.04.002_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1349-7006.2006.00244.x","article-title":"ERK MAP kinase in G cell cycle progression and cancer","volume":"97","author":"Torii","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jphs.2015.04.002_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1091\/mbc.E04-04-0339","article-title":"Gap junctions regulate extracellular signal-regulated kinase signaling to affect gene transcription","volume":"16","author":"Stains","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jphs.2015.04.002_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","article-title":"ERK and cell death: mechanisms of ERK-induced cell death\u2013apoptosis, autophagy and senescence","volume":"277","author":"Cagnol","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.jphs.2015.04.002_bib32","doi-asserted-by":"crossref","first-page":"H1956","DOI":"10.1152\/ajpheart.00407.2008","article-title":"ERKs\/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes","volume":"295","author":"Liu","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jphs.2015.04.002_bib33","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ymthe.2004.08.002","article-title":"AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study","volume":"10","author":"Immonen","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.jphs.2015.04.002_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1476-4598-9-141","article-title":"Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy","volume":"9","author":"Cottin","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jphs.2015.04.002_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2011.11.019","article-title":"Gap junctions propagate opposite effects in normal and tumor testicular cells in response to cisplatin","volume":"317","author":"Hong","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jphs.2015.04.002_bib36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3892\/or.2013.2894","article-title":"Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition","volume":"31","author":"Yang","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jphs.2015.04.002_bib37","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cellbi.2008.08.007","article-title":"Effects of 18-glycyrrhetinic acid on serine 368 phosphorylation of connexin43 in rat neonatal cardiomyocytes","volume":"32","author":"Liang","year":"2008","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jphs.2015.04.002_bib38","first-page":"L1018","article-title":"Inhibition of gap junction communication in alveolar epithelial cells by 18alpha-glycyrrhetinic acid","volume":"276","author":"Guo","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jphs.2015.04.002_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.taap.2009.10.012","article-title":"The B[a]P-increased intercellular communication via translocation of connexin-43 into gap junctions reduces apoptosis","volume":"242","author":"Tekpli","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jphs.2015.04.002_bib40","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/cdd.2008.196","article-title":"Connexin-related signaling in cell death: to live or let die?","volume":"16","author":"Decrock","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jphs.2015.04.002_bib41","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1038\/onc.2010.299","article-title":"Connexin43 inhibits the oncogenic activity of c-Src in C6 glioma cells","volume":"29","author":"Herrero-Gonzalez","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jphs.2015.04.002_bib42","doi-asserted-by":"crossref","first-page":"44852","DOI":"10.1074\/jbc.M305072200","article-title":"The gap junction-independent tumor-suppressing effect of connexin 43","volume":"278","author":"Zhang","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jphs.2015.04.002_bib43","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/jcb.20678","article-title":"Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells","volume":"97","author":"Ariyama","year":"2006","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jphs.2015.04.002_bib44","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.onc.1202034","article-title":"Bax cleavage is mediated by calpain during drug-induced apoptosis","volume":"17","author":"Wood","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.jphs.2015.04.002_bib45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/excr.2000.4859","article-title":"Cleavage of Bax enhances its cell death function","volume":"256","author":"Wood","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jphs.2015.04.002_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0304-3835(02)00552-9","article-title":"Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax","volume":"189","author":"Toyota","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jphs.2015.04.002_bib47","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3892\/etm.2011.270","article-title":"Bowman-Birk protease inhibitor from soybeans enhances cisplatin-induced cytotoxicity in human mesothelioma cells","volume":"2","author":"Kashiwagi","year":"2011","journal-title":"Exp Ther Med"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861315000754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861315000754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T03:33:55Z","timestamp":1589513635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861315000754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1347861315000754"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2015.04.002","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of enhanced expression of connexin 43 on sunitinib-induced cytotoxicity in mesothelioma cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2015.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}